Akbar Hedayatizadeh-Omran

Dr. Akbar Hedayatizadeh-Omran


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2020 in Neuropsychopharmacology Reports
Verified
Journal Article
Open access
PDF file
LHLeila Hassannia
Leila Hassannia
FTFatemeh Taghizadeh
Fatemeh Taghizadeh
MMMahmood Moosazadeh
Mahmood Moosazadeh
MZMehran Zarghami
Mehran Zarghami
HTHassan Taghizadeh
Hassan Taghizadeh
NDNiloufar Dehghan
Niloufar Dehghan
Background: The COVID‐19 outbreak has exerted a great deal of psychological pressure on Iranian health workers and the general population. The aim of this study was to determine the effect of pandemic on anxiety and depression in Iranian population.Methods: An online cross‐sectional study was conducted for the general public and healthcare workers in Iran using a questionnaire comprised of demographic questions and Hospital Anxiety and Depression Scale. Chi‐square test and univariate and multivariate logistic regression models were conducted.Results: Of the 2045 participants, 1136 (65.6%) were considered to have moderate and severe anxiety symptoms, and 865 (42.3%) had moderate and severe depression symptoms. The prevalence of anxiety was higher in the females than in the males (OR = 1.4, 95% CI: 1.123‐1.643, P = .002); the prevalence of anxiety was significantly higher in those aged 30‐39 years than in other age‐groups (OR = 1.6, 95% CI: 1.123‐2.320, P = .001); furthermore, the prevalence of anxiety and depression was significantly higher in doctors and nurses compared with other occupations ((OR = 1.9, 95% CI: 1.367‐2.491, P < .001) and (OR = 1.5, 95% CI: 1.154‐2.021, P = .003)). In addition, the prevalence of anxiety symptoms in the likely infected COVID‐19 group was higher than in the noninfected COVID‐19 group (OR = 1.35, 95% CI: 1.093‐1.654, P = .005).Conclusions: Regarding the high prevalence of anxiety and depression symptoms, especially among healthcare workers, appropriate psychological/psychiatric intervention necessitates.

8 September 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
SMSeyed Abbas Mousavi
Seyed Abbas Mousavi
KHKeyvan Heydari
Keyvan Heydari
HMHossein Mehravaran
Hossein Mehravaran
MSMajid Saeedi
Majid Saeedi
RAReza Alizadeh-Navaei
Reza Alizadeh-Navaei
ASAmir Shamshirian
Amir Shamshirian
This trial aims to evaluate the effectiveness of adding melatonin to the treatment protocol of hospitalized coronavirus disease 2019 (COVID‐19) patients. This was an open‐label, randomized controlled clinical trial in hospitalized COVID‐19 patients. Patients were randomized into a treatment arm receiving melatonin plus standard care or a control arm receiving standard care alone. The trial's primary endpoint was sleep quality examined by the Leeds Sleep Evaluation Questionnaire (LSEQ). The trial's secondary endpoints were symptoms alleviation by Day 7, intensive care unit admission, 10‐day mortality, white blood cell count, lymphocyte count, C‐reactive protein status, and peripheral capillary oxygen saturation. Ninety‐six patients were recruited and allocated to either the melatonin arm (n = 48) or control arm (n = 48). Baseline characteristics were similar across treatment arms. There was no significant difference in symptoms on Day 7. The mean of the LSEQ scores was significantly higher in the melatonin group (p < 0.001). There was no significant difference in laboratory data, except for blood oxygen saturation, which has improved significantly in the melatonin group compared with the control group (95.81% vs. 93.65% respectively, p = 0.003). This clinical trial study showed that the combination of oral melatonin tablets and standard treatment could substantially improve sleep quality and blood oxygen saturation in hospitalized COVID‐19 patients.

28 September 2020 in Hormone Molecular Biology and Clinical Investigation
Verified
Journal Article
Open access
ASAmir Shamshirian
Amir Shamshirian
KHKeyvan Heydari
Keyvan Heydari
ZSZahra Shams
Zahra Shams
Amir ArefAmir Aref
Amir Aref
DSDanial Shamshirian
Danial Shamshirian
RAReza Alizadeh-Navaei
Reza Alizadeh-Navaei
Objectives: Breast cancer is known as one of the deadliest forms of cancer, and it is increasing globally. There are a variety of proven and controversial risk factors for this malignancy. Herein, we aimed to undertake a systematic review and meta-analysis focus on the epidemiology of breast cancer risk factors in Iran. Methods: We performed a systematic search via PubMed, Scopus, Web of Science, and Persian databases for identifying studies published on breast cancer risk factors up to March 2019. Meta-analyses were done for risk factors reported in more than one study. We calculated odds ratios (ORs) with corresponding 95% confidence intervals (CIs) using a fixed/random-effects models. Results: Thirty-nine studies entered into the meta-analysis. Pooling of ORs showed a significant harmful effect for risk factors including family history (OR: 1.80, 95%CI 1.47–2.12), hormonal replacement therapy (HRT) (OR: 5.48, 95%CI 0.84–1.74), passive smokers (OR: 1.68, 95%CI 1.34–2.03), full-term pregnancy at age 30 (OR: 3.41, 95%CI 1.19–5.63), abortion (OR: 1.84, 95%CI 1.35–2.33), sweets consumption (OR: 1.71, 95%CI 1.32–2.11) and genotype Arg/Arg (crude OR: 1.59, 95%CI 1.07–2.10), whereas a significant protective effect for late menarche (OR: 0.58, 95%CI 0.32–0.83), nulliparity (OR: 0.68, 95%CI 0.39–0.96), 13–24 months of breastfeeding (OR: 0.68, 95%CI 0.46–0.90), daily exercise (OR: 0.59, 95%CI 0.44–0.73) and vegetable consumption (crude OR: 0.28, 95%CI 0.10–0.46). Conclusions: This study suggests that factors such as family history, HRT, passive smokers, late full-term pregnancy, abortion, sweets consumption and genotype Arg/Arg might increase risk of breast cancer development, whereas late menarche, nulliparity, 13–24 months breastfeeding, daily exercise and vegetable consumption had an inverse association with breast cancer development.

6 April 2020 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
VOVersa Omrani-Nava
Versa Omrani-Nava
IMIradj Maleki
Iradj Maleki
AAAbdolrahim Ahmadi
Abdolrahim Ahmadi
MMMahmood Moosazadeh
Mahmood Moosazadeh
AHAkbar Hedayatizadeh-Omran
Akbar Hedayatizadeh-Omran
RAReza Alizadeh-Navaei
Reza Alizadeh-Navaei
One of the most critical health issues in the world is the COVID-19 pandemic from the Coronaviridae family. There is a lack of knowledge regarding the disea ...

1 January 2019
Verified
Journal Article
Open access
PDF file
MMMahmood Moosazadeh
Mahmood Moosazadeh
IMIradj Maleki
Iradj Maleki
RAReza Alizadeh-Navaei
Reza Alizadeh-Navaei
MKMotahareh Kheradmand
Motahareh Kheradmand
AHAkbar Hedayatizadeh-Omran
Akbar Hedayatizadeh-Omran
ABAgil Barzegar
Agil Barzegar
Background: Neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR) and platelet-lymphocyte ratio (PLR) have a prognostic value in several types of diseases such as cancers and they vary in different races. So, we aimed to evaluate the normal range of these markers among healthy people to determine the normal value in Iranian population. ...

17 January 2020 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
ABAdeleh Bahar
Adeleh Bahar
ZKZahra Kashi
Zahra Kashi
MKMotahareh Kheradmand
Motahareh Kheradmand
AHAkbar Hedayatizadeh-Omran
Akbar Hedayatizadeh-Omran
MMMahdi Moradinazar
Mahdi Moradinazar
MMMahmood Moosazadeh
Mahmood Moosazadeh